| Entry |
|
|---|
| Name |
Salicylamide (JAN/USP/INN);
Salicylamide (TN) |
|---|
| Formula |
C7H7NO2
|
|---|
| Exact mass |
137.0477
|
|---|
| Mol weight |
137.136
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
|
|---|
| Remark |
| Product (mixture): | D04044<JP> D04046<JP> |
|
|---|
| Efficacy |
Analgesic |
|---|
| Comment |
Salicylic acid derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N02 ANALGESICS
N02B OTHER ANALGESICS AND ANTIPYRETICS
N02BA Salicylic acid and derivatives
N02BA05 Salicylamide
D01811 Salicylamide (JAN/USP/INN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for nervous and sensory systems
01 Cold remedy (oral use)
D01811 Salicylamide (JAN/USP/INN)
03 Antipyretic analgesic agents
D01811 Salicylamide (JAN/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Designated second-class OTC drugs
Inorganic and organic chemicals
Salicylamide
D01811 Salicylamide (JAN/USP/INN)
Second-class OTC drugs
Inorganic and organic chemicals
Salicylamide
D01811 Salicylamide (JAN/USP/INN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01504 Nonsteroidal anti-inflammatory drug (NSAID)
DG01909 Anti-inflammatory drug, salicylic acid derivatives
D01811 Salicylamide
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Prostaglandin synthase
PTGS1 (COX1)
D01811 Salicylamide (JAN/USP/INN)
PTGS2 (COX2)
D01811 Salicylamide (JAN/USP/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 10
1 C8x C 23.9552 -17.7951
2 C8x C 23.9552 -19.1953
3 C8x C 25.1707 -19.8954
4 C8x C 26.3792 -19.1953
5 C8y C 26.3792 -17.7951
6 C8y C 25.1707 -17.0949
7 C5a C 25.1724 -15.6947
8 N1a N 26.3859 -14.9961
9 O5a O 23.9608 -14.9931
10 O1a O 27.5923 -17.0958
BOND 10
1 4 5 1
2 5 6 2
3 6 1 1
4 6 7 1
5 1 2 2
6 7 8 1
7 2 3 1
8 7 9 2
9 3 4 2
10 5 10 1
|
|---|
